Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

about

Efficacy of betahistine plus cognitive behavioral therapy on residual dizziness after successful canalith repositioning procedure for benign paroxysmal positional vertigo

P2860

Q59135098-51261A2C-4ABA-4BCB-8AF1-71EE8C46F202

P2860

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

Item

http://www.wikidata.org/entity/Q57155162

description

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 19 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

@en

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

@nl

type

Item

label

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

@en

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

@nl

prefLabel

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

@en

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

@nl

P1476

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

@en

P2093

Chan-Juan Zhou

http://www.w3.org/2001/XMLSchema#string

Hai-Yang Wang

http://www.w3.org/2001/XMLSchema#string

Liang Fang

http://www.w3.org/2001/XMLSchema#string

Peng Xie

http://www.w3.org/2001/XMLSchema#string

Peng Zheng

http://www.w3.org/2001/XMLSchema#string

Shun-Jie Bai

http://www.w3.org/2001/XMLSchema#string

Wen-Wen Li

http://www.w3.org/2001/XMLSchema#string

Yi-Yun Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The human urine metabolome

Melatonin for pre- and postoperative anxiety in adults

The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care

Treating comorbid anxiety and depression: Psychosocial and pharmacological approaches

The assessment of anxiety states by rating

Analysis of metabolomic data using support vector machines.

Epidemiology of mental disorders in children and adolescents.

Novel urinary metabolite signature for diagnosing postpartum depression

Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking.

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

P2888

s41398-018-0245-0

P304

192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41398-018-0245-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jian-Jun Chen

P577

2018-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107084281

http://www.w3.org/2001/XMLSchema#string

P698

30232320

http://www.w3.org/2001/XMLSchema#string

P921

biological psychiatry

biomarker

P932

6145889

http://www.w3.org/2001/XMLSchema#string

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

about

P2860

P2860

Urinary biomarker panel for diagnosing patients with depression and anxiety disorders

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932